Eliana Lacerda

Eliana Mattos Lacerda MD, PhD, MSc, is a Clinical Assistant Professor and part of the CureME team at the London School of Hygiene and Tropical Medicine, London, UK. She oversees the UK ME/CFS biobank, from recruitment of participants through to release of samples.

She has a medical background, with training in public health and occupational health.

EUROMENE
Dr. Lacerda is the Vice Chair of EUROMENE, a European Union not-for-profit research organization committed to tackling the cause and treatment for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome, and was a founder member of the network.

ME/CFS Common Data Element (CDE) Project
Member of the Baseline/Covariate Working Group and Neurologic/Cognitive/CNS Imaging Working group of the Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Common Data Element (CDE) Project sponsored by the National Institute of Neurological Disorders and Stroke and the Centers for Disease Control and Prevention.

Notable studies

 * 2010, Exploring the feasibility of establishing a disease-specific post-mortem tissue bank in the UK: a case study in ME/CFS - (Abstract)
 * 2011, A Disease Register for ME/CFS: Report of a Pilot Study - (Full Text)
 * 2011, Social support needs for equity in health and social care: a thematic analysis of experiences of people with chronic fatigue syndrome/myalgic encephalomyelitis - (Full Text)
 * 2011, Prevalence of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) in three regions of England: a repeated cross-sectional study in primary care - (Full Text)
 * 2011, The functional status and well being of people with myalgic encephalomyelitis/chronic fatigue syndrome and their carers - (Full Text)
 * 2014, Considerations in establishing a post-mortem brain and tissue bank for the study of myalgic encephalomyelitis/chronic fatigue syndrome: A proposed protocol - (Full Text)
 * 2017, How have selection bias and disease misclassification undermined the validity of myalgic encephalomyelitis/chronic fatigue syndrome studies? - (Full Text)
 * 2017, The UK ME/CFS Biobank for biomedical research on Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) and Multiple Sclerosis - (Full text)
 * 2017, The European ME/CFS Biomarker Landscape project: an initiative of the European network EUROMENE - (Full Text)
 * 2017, Editorial - Using a participatory approach to develop and implement the UK ME/CFS Biobank
 * 2018, Functional Status and Well-Being in People with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Compared with People with Multiple Sclerosis and Healthy Controls - (Full Text)
 * 2018, Prevalence and incidence of myalgic encephalomyelitis/chronic fatigue syndrome in Europe—the Euro-epiME study from the European network EUROMENE: a protocol for a systematic review - (Full text)
 * 2018, The UK ME/CFS Biobank: A Disease-Specific Biobank for Advancing Clinical Research Into Myalgic Encephalomyelitis/Chronic Fatigue Syndrome - (Full text)
 * 2019, Hope, disappointment and perseverance: Reflections of people with Myalgic encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) and Multiple Sclerosis participating in biomedical research. A qualitative focus group study.
 * 2019, Evidence of Clinical Pathology Abnormalities in People with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) from an Analytic Cross-Sectional Study - (Abstract)
 * 2019, Cellular Immune Function in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) - (Full text)
 * 2019, HERV-K and HERV-W transcriptional activity in Myalgic Encephalomyelitis/ Chronic Fatigue Syndrome - (Full text)
 * 2019, Myalgic Encephalomyelitis/Chronic Fatigue Syndrome as a hyper-regulated immune system driven by an interplay between regulatory T cells and chronic human herpesvirus infections - (Abstract)
 * 2019, A logistic regression analysis of risk factors in ME/CFS pathogenesis - (Full text)
 * 2019, How Myalgic Encephalomyelitis / Chronic Fatigue Syndrome (ME/CFS) Progresses: A Framework for Research and the Prevention, Treatment, and Rehabilitation in ME/CFS - (Full text)
 * 2020, Systematic Review of the Epidemiological Burden of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Across Europe: Current Evidence and EUROMENE Research Recommendations for Epidemiology - (Full text)
 * 2021, The SARS-CoV-2 receptor angiotensin-converting enzyme 2 (ACE2) in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: analysis of high-throughput epigenetic and gene expression studies - (Full text)

Talks and interviews

 * 2018, UK CFS/ME Research Collaborative Conference - European collaboration in ME/CFS: The EUROMENE network
 * 14 Mar 2019, The European Network on ME/CFS – How Best to Connect Research & Healthcare Across Europe, given at the International Research Symposium, Geelong, Australia, sponsored by Emerge Australia

Learn more

 * LSHTM bio